Renal Cell Carcinoma Clinical Management /
Renal Cell Carcinoma: Clinical Management provides a comprehensive, state-of-the art review of this field, and will serve as a valuable resource for clinicians, surgeons and researchers with an interest in kidney cancer. The volume reviews new data about risk factors for the disease, profiles the ne...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | , |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Totowa, NJ :
Humana Press : Imprint: Humana Press,
2013.
|
| Σειρά: | Current Clinical Urology
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Section I: Localized Disease
- 1.Etiology of RCC: Incidence, Demographics, and Environmental Factors
- 2.Pathology of Renal Cell Carcinoma
- 3.Familial Renal Cell Carinoma
- 4.Imaging of Renal Cell Carcinoma
- 5.Prognostic Factors for Localized Renal Cell Carcinoma
- Section II: Management of Localized RCC
- 6.Assessment of Oncologic Risk for Clinical Stage T1 Renal Tumors and the Emerging Role of Renal Mass Biopsy
- 7.Radical Nephrectomy for Localized Renal Tumors: Oncological and Renal Functional Considerations
- 8.Nephron-Sparing Surgery for Renal Cancer
- 9.Thermal Ablation
- 10.Active Surveillance of the Small Renal Mass
- Section III: Locally Advanced Disease
- 11.Locally Advanced Renal Cell Carcinoma
- 12.Neoadjuvant Targeted Therapy and Consolidative Surgery
- Section IV: Advanced Disease
- 13.Biology of RCC (VEGF, mTOR, immune aspects)
- 14.Prognostic Factors in Advanced Renal Cell Carcinoma
- 5.Integration of Surgery in Metastatic Renal Cancer
- 16.Immunotherapy for Renal Cell Carcinoma
- 17.Targeted Therapy: Vascular Endothelial Growth Factor (VEGF)
- 18.mTOR in Renal cell carcinoma
- 19.Palliative and Supportive Care for Renal Cancer.
